IL126145A0 - Immunity to trypanosomatids species - Google Patents

Immunity to trypanosomatids species

Info

Publication number
IL126145A0
IL126145A0 IL12614597A IL12614597A IL126145A0 IL 126145 A0 IL126145 A0 IL 126145A0 IL 12614597 A IL12614597 A IL 12614597A IL 12614597 A IL12614597 A IL 12614597A IL 126145 A0 IL126145 A0 IL 126145A0
Authority
IL
Israel
Prior art keywords
trypanosomatids
immunity
species
trypanosomatids species
Prior art date
Application number
IL12614597A
Original Assignee
Sovarec S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sovarec S A filed Critical Sovarec S A
Publication of IL126145A0 publication Critical patent/IL126145A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12614597A 1996-03-12 1997-03-12 Immunity to trypanosomatids species IL126145A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96200665 1996-03-12
EP96201343 1996-05-15
PCT/EP1997/001289 WO1997033999A1 (en) 1996-03-12 1997-03-12 Immunity to trypanosomatids species

Publications (1)

Publication Number Publication Date
IL126145A0 true IL126145A0 (en) 1999-05-09

Family

ID=26142593

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12614597A IL126145A0 (en) 1996-03-12 1997-03-12 Immunity to trypanosomatids species

Country Status (12)

Country Link
EP (1) EP0896623A1 (en)
JP (1) JP2000507098A (en)
CN (1) CN1216584A (en)
AU (1) AU733720B2 (en)
BR (1) BR9708188A (en)
CA (1) CA2248684A1 (en)
IL (1) IL126145A0 (en)
MA (1) MA25182A1 (en)
NZ (1) NZ331889A (en)
TN (1) TNSN97045A1 (en)
TR (1) TR199801776T2 (en)
WO (1) WO1997033999A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS52507B (en) * 2003-11-05 2013-04-30 Laboratorios Leti S.L. Use of specific histones for the treatment of parasitic diseases
FR2952382B1 (en) * 2009-11-10 2011-11-25 Univ Victor Segalen Bordeaux 2 VACCINES AND DIAGNOSES AGAINST AFRICAN ANIMAL TRYPANOSOMOSES
BRPI1003744B1 (en) * 2010-06-08 2021-10-26 Universidade Federal De Ouro Preto RECOMBINANT E-NTPDASES, USE IN THE PRODUCTION OF DIAGNOSTIC KIT FOR ANTIBODY DETECTION IN LEISHMANIASIS CAUSED BY SPECIES OF THE GENUS LEISHMANIA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8722741D0 (en) * 1987-09-28 1987-11-04 Hoffmann La Roche Induction of cytotoxic t cell response

Also Published As

Publication number Publication date
CA2248684A1 (en) 1997-09-18
JP2000507098A (en) 2000-06-13
TNSN97045A1 (en) 2005-03-15
WO1997033999A1 (en) 1997-09-18
MA25182A1 (en) 2001-07-02
BR9708188A (en) 2000-01-18
CN1216584A (en) 1999-05-12
NZ331889A (en) 2000-12-22
AU733720B2 (en) 2001-05-24
AU2027297A (en) 1997-10-01
TR199801776T2 (en) 1998-12-21
EP0896623A1 (en) 1999-02-17

Similar Documents

Publication Publication Date Title
GB9610911D0 (en) Improvements relating to closures
EP0895545A4 (en) Novel protein - traf6
ZA972591B (en) Substituted 1-methyl-3-benzyluracils
ZA9711235B (en) Substituted pyrazol-3-ylbenzazoles
IL126145A0 (en) Immunity to trypanosomatids species
PL332278A1 (en) Novel methods
GB9812599D0 (en) Improvements realting to sheleving units
GB9426105D0 (en) Improvements relating to electrolevels
ZA983900B (en) Process to 5-methyleneoxazolenes
IL113603A0 (en) Novel substituted benzimidalozes
PL328019A1 (en) Novel phenantidines
GB9714143D0 (en) Improvements relating to fastening devices
GB9619202D0 (en) Improvements to subsills
GB9601057D0 (en) Improvements to rotorcraf
GB2317241B (en) Improvements relating to lighting means
GB9418374D0 (en) Improvements to spear-guns
TW307986U (en) Decoration
GB9604388D0 (en) Improvements relating to stairnosings
GB9608813D0 (en) Pyridinyl-2-cyclopenten-1-ones as selctive cyclooxygenase-2-inhibitors
GB9611474D0 (en) Improvements relating to design
GB2313146B (en) Improvements relating to buildings
GB9401711D0 (en) Improvements relating to mocro-analytical techniques
GB9624295D0 (en) Improvements to luminaires
GB9612232D0 (en) Improvements relating to windows
ZA977996B (en) Novel methods